HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (34) Citing Articles via Google Scholar Google Scholar Articles by Cheng, S-L. Articles by Yang, P-C. Search for Related Content PubMed PubMed Citation Articles by Cheng, S-L. Articles by Yang, P-C.

Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD

¹ Dept of Internal Medicine, Far Eastern Memorial Hospital, ² Dept of Internal Medicine, National Taiwan University Hospital, ³ Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taiwan

CORRESPONDENCE: C-J. Yu, Dept of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan. Fax: 886 2 23585867 E-mail:Jeffery@ha.mc.ntu.edu.tw

Keywords: Chronic obstructive pulmonary disease, epoxide hydrolase, glutathione S-transferase, polymorphism

Received: September 15, 2003
Accepted January 28, 2004

Genetic susceptibility to the development of chronic obstructive pulmonary disease (COPD) might depend on variation in the activities of enzymes that detoxify cigarette smoke products, such as microsomal epoxide hydrolase (mEPHX) and glutathione S-transferase (GST). It was investigated whether polymorphisms in these genes had any association with susceptibility to COPD and COPD severity.

The genotypes of 184 patients with COPD and 212 control subjects were determined by polymerase chain reaction followed by restriction fragment length polymorphism analysis of the mEPHX, GSTM1, GSTT1 and GSTP1 genes. All subjects were smokers or exsmokers.

The proportion of GSTM1-null genotypes was significantly higher in patients with COPD than in control subjects (61.4 versus 42.5%). No differences were observed in the frequency of polymorphic genotypes for mEPHX, GSTT1 and GSTP1. During combined analysis of genetic polymorphisms for mEPHX, GSTM1 and GSTP1, it was found that there are strong indicators for susceptibility to COPD (genotype combination with at least one mutant mEPHX exon-3 allele (histidine 113), GSTM1 null and homozygous for the GSTP1 isoleucine 105 allele). The frequencies of homozygous mutant alleles of mEPHX exon 3 and the GSTM1-null genotype were significantly higher in patients with severe COPD (forced expiratory volume in one second of <35% of the predicted value).

It is proposed that the combination of genetic variants including at least one mutant microsomal epoxide hydrolase exon-3 allele and glutathione S-transferase M1-null and homozygous isoleucine 105 glutathione S-transferase P1 genotypes are significant indicators of susceptibility to chronic obstructive pulmonary disease in the Taiwanese population. In addition, the homozygous variant of microsomal epoxide hydrolase exon 3 and the glutathione S-transferase M1-null genotype are independent risk factors for developing severe chronic obstructive pulmonary disease.

This article has been cited by other articles:

				S J Marciniak and D A Lomas What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax, April 1, 2009; 64(4): 359 - 364. [Abstract] [Full Text] [PDF]

				A R Bentley, P Emrani, and P A Cassano Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review Thorax, November 1, 2008; 63(11): 956 - 961. [Abstract] [Full Text] [PDF]

				M. Siedlinski, D. S. Postma, C. C. van Diemen, A. Blokstra, H. A. Smit, and H. M. Boezen Lung Function Loss, Smoking, Vitamin C Intake, and Polymorphisms of the Glutamate-Cysteine Ligase Genes Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 13 - 19. [Abstract] [Full Text] [PDF]

				Z. Ammous, N. R. Hackett, M. W. Butler, T. Raman, I. Dolgalev, T. P. O'Connor, B.-G. Harvey, and R. G. Crystal Variability in Small Airway Epithelial Gene Expression Among Normal Smokers Chest, June 1, 2008; 133(6): 1344 - 1353. [Abstract] [Full Text] [PDF]

				C. P. Hersh, D. L. DeMeo, and E. K. Silverman National Emphysema Treatment Trial State of the Art: Genetics of Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493. [Abstract] [Full Text] [PDF]

				M. T Salam, P.-C. Lin, E. L Avol, W J. Gauderman, and F. D Gilliland Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma Thorax, December 1, 2007; 62(12): 1050 - 1057. [Abstract] [Full Text] [PDF]

				A. G. Schwartz and J. C. Ruckdeschel Familial Lung Cancer: Genetic Susceptibility and Relationship to Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 16 - 22. [Abstract] [Full Text] [PDF]

				V L Kinnula Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases Thorax, August 1, 2005; 60(8): 693 - 700. [Abstract] [Full Text] [PDF]

				J. Hang, W. Zhou, X. Wang, H. Zhang, B. Sun, H. Dai, L. Su, and D. C. Christiani Microsomal Epoxide Hydrolase, Endotoxin, and Lung Function Decline in Cotton Textile Workers Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 165 - 170. [Abstract] [Full Text] [PDF]

				S. Teramoto, T. Ishii, H. Yamamoto, Y. Yamaguchi, T. Matsuse, and N. A. Molfino Xenobiotic Enzymes and Genetics of COPD Chest, January 1, 2005; 127(1): 408 - 409. [Full Text] [PDF]